Clinical trial
Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia: A Prospective Multicenter Study
NCT04276155 is registered in ClinicalTrials.gov with Centre Hospitalier de PAU as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia: A Prospective Multicenter Study
- Lead sponsor
- Centre Hospitalier de PAU
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- August 3, 2021
- Completion date
- June 22, 2027
- Enrollment
- 500 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, myocardial infarction